CClinicalTrials.gg
CompletedNCT04364165U=UUpdated Feb 26, 2024Results posted

Effect of U=U Messaging on HIV in South Africa

An interventional study of Standard invitation to free HIV testing at mobile clinic and U=U messaging and invitation to free HIV testing at mobile clinic in HIV/AIDS, sponsored by University of Pennsylvania. Completed at 1 site in South Africa. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-26.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
1,048
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

This cluster randomized trial will investigate whether messaging about being undetectable equals untransmittable (U=U) designed through a participatory, user-centered approach increases HIV testing uptake within men in Klipfontein Mitchells Plain (KMP) district in Cape Town, South Africa.

Read the detailed description

This study will investigate the effect of participatory, user designed messaging to increase knowledge about U=U on HIV testing uptake within men in the Klipfontein Mitchells Plain (KMP) district, a resource-limited, densely populated, high HIV disease burden area in Cape Town, through a cluster randomized trial design. The study will be conducted in two phases: Phase 1 is a participatory, human-centered design framework will be used to develop U=U messages to increase HIV testing uptake in men. Phase 2 is a cluster randomized trial that will determine the effect of U=U messaging on HIV testing uptake. The primary outcome will be HIV testing uptake at a community-based mobile clinic. Secondary outcomes will include the proportion of males tested who are HIV-positive (and newly HIV positive).

Men in the intervention group will receive invitation cards for mobile HIV testing that contain U=U messages. Men in the control group will receive invitation cards for mobile HIV testing that contain standard messaging. Mobile clinic days (i.e. clusters of men receiving invitation cards on a single day) will be the unit of randomization. Recruitment will be conducted by trained mobile clinic staff at high foot-traffic sites in the KMP community. Recruitment efforts will be focus on young men in multiple mobile testing sites that are located in areas within KMP.

02

Conditions studied

  • HIV/AIDS

Keywords

  • Behavioral sciences
  • HIV testing
03

In context

Acquired Immunodeficiency Syndrome

2,040 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 272 are open to participants now.

This study's enrollment of 1,048 is above the median of 105 across 1,543 interventional studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Men at least 18 years of age within the vicinity of the mobile Tutu Tester HIV testing mobile clinic

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,048 participants (actual)

Study arms

  • Experimental
    Standard of care messaging

    On mobile clinic days randomized to standard of care messaging, participants will receive standard invitation cards distributed at the Tutu Tester containing basic information encouraging HIV testing. Messages will encourage men to come in for HIV testing at the mobile clinic on the same day. A mobile clinic recruiter will deliver the standard invitation card and share a brief script including the standard Tutu Tester message that free HIV testing is available at the Tutu Tester, with no further information or motivation to test.

    Behavioral: Standard invitation to free HIV testing at mobile clinic

  • Experimental
    U=U messaging

    On mobile clinic days randomized to U=U messaging, participants will receive the U=U invitation cards distributed at the Tutu Tester that will seek to assuage the fears of testing HIV positive by conveying the message that HIV treatment makes it possible for HIV positive people to be untransmittable and to live normal lives. Messages will encourage men to come in for HIV testing at the mobile clinic on the same day. A mobile clinic recruiter will deliver the U=U invitation card and share a brief script asking people if they knew they could control HIV and that pills exist that can keep them healthy and ensure they don't transmit the virus to their sex partners, and that free HIV testing is available at the Tutu Tester.

    Behavioral: U=U messaging and invitation to free HIV testing at mobile clinic

Interventions

  • BehavioralStandard invitation to free HIV testing at mobile clinic

    Participants receive standard invitation to same day HIV testing at mobile clinic.

  • BehavioralU=U messaging and invitation to free HIV testing at mobile clinic

    Participants receive messaging about being undetectable equals untransmittable (U=U) and invitation to same day HIV testing at mobile clinic.

06

What researchers measure

Primary outcomes

  1. HIV Testing Uptake

    Number of Participants that were Invited and Came for HIV Testing

    Time frame: Recruitment took place over 12 days.

Secondary outcomes

  1. HIV Positivity

    Number of Participants that Came for Testing and Obtained an HIV-Positive Result

    Time frame: Recruitment took place over 12 days.

07

Results

Posted Feb 26, 2024

Participant flow

Peer promoters were trained to deliver brief messages to men at selected high foot-traffic sites in the KMP community. Males ≥ 18 years of age within the vicinity of the mobile Tutu Tester HIV testing van and willing to consent to participate in the study were eligible for inclusion.

Participant flow — Overall Study
MilestoneStandard of Care MessagingU=U Messaging
Started544504
Completed68112
Not completed476392

Outcome measures

PrimaryHIV Testing Uptake

Number of Participants that were Invited and Came for HIV Testing

Time frame:
Recruitment took place over 12 days.
Reported as:
Count of participants · Participants
HIV Testing Uptake
ParticipantsStandard of Care MessagingU=U Messaging
HIV Testing Uptake68112
Statistical analysis
  • Standard of Care Messaging vs U=U Messaging · Regression, Logistic · p = .01 · Odds ratio (or): 2 · 95% CI 1.44 to 2.78
SecondaryHIV Positivity

Number of Participants that Came for Testing and Obtained an HIV-Positive Result

Time frame:
Recruitment took place over 12 days.
Reported as:
Count of participants · Participants
HIV Positivity
ParticipantsStandard of Care MessagingU=U Messaging
HIV Positivity37
Statistical analysis
  • Standard of Care Messaging vs U=U Messaging · Regression, Logistic · p = .41 · Odds ratio (or): 1.44 · 95% CI 0.36 to 5.78

Adverse events

Collected over 1 day from recruitment. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard of Care Messaging0/544 (0%)0/544 (0%)0/544 (0%)
U=U Messaging0/504 (0%)0/504 (0%)0/504 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Standard of Care MessagingU=U MessagingTotal
Median34 (26 to 44)35 (28 to 46)35 (27 to 45)
Sex: Female, Male
Sex: Female, Male(Participants)Standard of Care MessagingU=U MessagingTotal
Female000
Male68112180
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Standard of Care MessagingU=U MessagingTotal
Black or mixed race68112180
Region of Enrollment
Region of Enrollment(participants)Standard of Care MessagingU=U MessagingTotal
South Africa68112180
08

Study locations

1 site
  • Desmond Tutu HIV Foundation
    Cape Town, Western Cape 7925, South Africa
09

References and documents

Publications

  • Smith PJ, Joseph Davey DL, Schmucker L, Bruns C, Bekker LG, Medina-Marino A, Thirumurthy H, Buttenheim AM. Participatory Prototyping of a Tailored Undetectable Equals Untransmittable Message to Increase HIV Testing Among Men in Western Cape, South Africa. AIDS Patient Care STDS. 2021 Nov;35(11):428-434. doi: 10.1089/apc.2021.0101. PubMed 34739334 ↗

Study documents

  • Protocol and statistical analysis plan · Oct 31, 2019
  • Informed consent form · Jan 15, 2020

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04364165
Lead sponsor
University of Pennsylvania
Collaborators
Desmond Tutu HIV Foundation, Bill and Melinda Gates Foundation
Responsible party
Sponsor
First posted
Apr 27, 2020
Start date
Mar 2, 2020
Primary completion
Mar 18, 2020
Completion
Aug 1, 2020
Results posted
Feb 26, 2024
Last update
Feb 26, 2024

Study contacts

Alison Buttenheim, PhD
principal investigator · University of Pennsylvania
Dvora Joseph Davey
principal investigator · Desmond Tutu HIV Foundation

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion